Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
ReTo Eco-Solutions | RETO | Nov 27, 2024 | 1.00 | +1.01 |
Retractable Technologies | RVP | Nov 27, 2024 | 0.61 | +0.16 |
REV Group | REVG | Nov 27, 2024 | 30.85 | 0.00 |
Revance Therapeutics | RVNC | Nov 27, 2024 | 3.78 | -5.97 |
Revelation Biosciences | REVB | Nov 27, 2024 | 0.76 | +0.99 |
Revenueshares Largecap | RWL | Nov 27, 2024 | 103.90 | -0.02 |
Revenueshares Midcap | RWK | Nov 27, 2024 | 125.27 | -0.35 |
Revenueshares Smallcap | RWJ | Nov 27, 2024 | 48.92 | +0.16 |
Revenueshares Ultra Dividend Fund | RDIV | Nov 27, 2024 | 52.66 | +0.11 |
Reviva Pharmaceuticals | RVPH | Nov 27, 2024 | 1.14 | +1.79 |
Revolution Medicines | RVMD | Nov 27, 2024 | 58.58 | -0.09 |
Revolve Group A | RVLV | Nov 27, 2024 | 36.93 | -4.82 |
Revvity | RVTY | Nov 27, 2024 | 116.23 | +1.01 |
REX American Resources | REX | Nov 27, 2024 | 43.25 | +0.70 |
Rexford Industrial Realty | REXR | Nov 27, 2024 | 42.55 | +0.47 |
Rexford Industrial Realty B Pref | REXR-B | Nov 27, 2024 | 23.03 | +0.74 |
Rexford Industrial Realty C Pref | REXR-C | Nov 27, 2024 | 22.48 | +0.21 |
Reynolds Consumer Products | REYN | Nov 27, 2024 | 27.64 | -0.40 |
Rezolute | RZLT | Nov 27, 2024 | 4.99 | +4.18 |
Rezolve AI Limited - Ordinary Shares | RZLV | Nov 27, 2024 | 2.21 | -1.34 |
RF Acquisition A | RFAC | Nov 27, 2024 | 11.46 | 0.00 |
RF Acquisition Corp II | RFAIU | Nov 27, 2024 | 10.60 | +3.31 |
RF Acquisition II | RFAI | Nov 27, 2024 | 10.20 | +0.28 |
RF Industries | RFIL | Nov 27, 2024 | 4.11 | -1.20 |
RGC Resources | RGCO | Nov 27, 2024 | 20.90 | +1.11 |
RH | RH | Nov 27, 2024 | 386.56 | +0.24 |
Rhinebeck Bancorp | RBKB | Nov 27, 2024 | 9.81 | -0.30 |
Rhythm Pharmaceuticals | RYTM | Nov 27, 2024 | 62.25 | +0.48 |
Ribbon Communications | RBBN | Nov 27, 2024 | 3.76 | -2.84 |
Richardson Electronics | RELL | Nov 27, 2024 | 14.29 | +1.20 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.